Xeris nets $39.1M via FOPO

14:40 EST 14 Feb 2020 | Elsevier Business Intelligence

Xeris Pharmaceuticals Inc. netted $35.1M through a follow-on public offering of 9M common shares at $4.15 each. The company w...

Original Article: Xeris nets $39.1M via FOPO


More From BioPortfolio on "Xeris nets $39.1M via FOPO"

Quick Search

Relevant Topic

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...